0001493152-23-042180.txt : 20231121 0001493152-23-042180.hdr.sgml : 20231121 20231120194522 ACCESSION NUMBER: 0001493152-23-042180 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231120 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231121 DATE AS OF CHANGE: 20231120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRxADE HEALTH, INC CENTRAL INDEX KEY: 0001382574 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39199 FILM NUMBER: 231424184 BUSINESS ADDRESS: STREET 1: 2420 BRUNELLO TRACE CITY: LUTZ STATE: FL ZIP: 33558 BUSINESS PHONE: (800) 261 0281 MAIL ADDRESS: STREET 1: 2420 BRUNELLO TRACE CITY: LUTZ STATE: FL ZIP: 33558 FORMER COMPANY: FORMER CONFORMED NAME: TRXADE GROUP, INC. DATE OF NAME CHANGE: 20140207 FORMER COMPANY: FORMER CONFORMED NAME: XCELLINK INTERNATIONAL INC. DATE OF NAME CHANGE: 20081230 FORMER COMPANY: FORMER CONFORMED NAME: Bluebird Exploration Co. DATE OF NAME CHANGE: 20061204 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): November 20, 2023

TRxADE HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-39199

46-3673928

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

2420 Brunello Trace, Lutz, Florida		33558
(Address of principal executive offices)		(Zip Code)

(800) 261-0281

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
Common Stock, par value $0.00001 per share		MEDS		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On November 15, 2023 TRxADE HEALTH, Inc., a Delaware corporation (the “Company”), filed a Notification of Late Filing on Form 12b-25 reporting that it required additional time to complete its Quarterly Report on Form 10-Q for the period ending September 30, 2023 (the “Form 10-Q”), principally because the Company was in the process of preparing the financial statements for the quarter but needed additional time to complete such financial statements.

This Current Report on Form 8-K is being filed to report that the Company will not be filing the Form 10-Q withing the five-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended. To date, the Company has been unable, without unreasonable effort or expense, to complete the Form 10-Q, and its independent auditors have been unable to complete the review thereof.

The Company is continuing in its efforts to file the Form 10-Q as soon as reasonably practicable and expects to do so by December 15, 2023. As a result of this failure to file the Form 10-Q, the Company anticipates that it will receive a corresponding notice of non-compliance from Nasdaq. The Company anticipates that the notice from Nasdaq will have a grace period within which to file the Form 10-Q and regain compliance with the Nasdaq Listing Rules and that the Company will file the Form 10-Q within the grace period.

Item 9.01. Exhibits

Exhibit No.		Description of Exhibit
104		Inline XBRL for the cover page of this Current Report on Form 8-K

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	TRxADE HEALTH, INC.

	By:	/s/ Suren Ajjarapu
	Name:	Suren Ajjarapu
	Title:	Chief Executive Officer

Dated: November 20, 2023

EX-101.SCH 2 meds-20231120.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 meds-20231120_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 meds-20231120_pre.xml XBRL PRESENTATION FILE XML 5 R1.htm IDEA: XBRL DOCUMENT

Cover	Nov. 20, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Nov. 20, 2023
Entity File Number	001-39199
Entity Registrant Name	TRxADE HEALTH, INC.
Entity Central Index Key	0001382574
Entity Tax Identification Number	46-3673928
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2420 Brunello Trace
Entity Address, City or Town	Lutz
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33558
City Area Code	(800)
Local Phone Number	261-0281
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.00001 per share
Trading Symbol	MEDS
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 6 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001382574 2023-11-20 2023-11-20 iso4217:USD shares iso4217:USD shares false 0001382574 8-K 2023-11-20 TRxADE HEALTH, INC. DE 001-39199 46-3673928 2420 Brunello Trace Lutz FL 33558 (800) 261-0281 false false false false Common Stock, par value $0.00001 per share MEDS NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:G%C:^?VZH:TE[V ME-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P! MQ+MTFF6SU%L,9KD8M;:X1+_)UW,#ECQ ,ZE._<]'<')O$8 MT.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6 MJ6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5 M%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0 M ( *J==%&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&R MGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0 MDBBZ0=@S9)[NF:*'3^ 5!+ M P04 " "JG71799!YDAD! #/ P $P %M#;VYT96YT7U1Y<&5S72YX M;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85- MK'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+ MY8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-FI6.5Z*U .EK >MKBRAE# MVQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/) MW55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_ ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0 ( *J==%<'04UB@0 +$ 0 M " 0 !D;V-0&UL4$L! A0#% @ JIUT M5Y16[]GN *P( !$ ( !KP &1O8U!R;W!S+V-O&UL4$L! A0#% @ JIUT5YE&PO=V]R:W-H965T&UL4$L! A0#% @ JIUT5Y^@&_"Q @ X@P T ( ! ME@P 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL M4$L! A0#% @ JIUT5R0>FZ*M ^ $ !H ( !NQ$ M 'AL+U]R96QS+W=O9(9 0 SP, !, ( !H!( %M#;VYT96YT7U1Y<&5S72YX 8;6Q02P4& D "0 ^ @ ZA, end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://trxadehealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm meds-20231120.xsd meds-20231120_lab.xml meds-20231120_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "MEDS", "nsuri": "http://trxadehealth.com/20231120", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "meds-20231120.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "meds-20231120_lab.xml" ] }, "presentationLink": { "local": [ "meds-20231120_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://trxadehealth.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-20", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-20", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://trxadehealth.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001493152-23-042180-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-042180-xbrl.zip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c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